1. Home
  2. BOLT vs SAG Comparison

BOLT vs SAG Comparison

Compare BOLT & SAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • SAG
  • Stock Information
  • Founded
  • BOLT 2015
  • SAG 1975
  • Country
  • BOLT United States
  • SAG Singapore
  • Employees
  • BOLT N/A
  • SAG N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • SAG
  • Sector
  • BOLT Health Care
  • SAG
  • Exchange
  • BOLT Nasdaq
  • SAG NYSE
  • Market Cap
  • BOLT 22.6M
  • SAG 19.3M
  • IPO Year
  • BOLT 2021
  • SAG 2024
  • Fundamental
  • Price
  • BOLT $0.44
  • SAG $0.78
  • Analyst Decision
  • BOLT Hold
  • SAG
  • Analyst Count
  • BOLT 5
  • SAG 0
  • Target Price
  • BOLT $1.25
  • SAG N/A
  • AVG Volume (30 Days)
  • BOLT 105.0K
  • SAG 1.3M
  • Earning Date
  • BOLT 03-20-2025
  • SAG 12-19-2024
  • Dividend Yield
  • BOLT N/A
  • SAG N/A
  • EPS Growth
  • BOLT N/A
  • SAG N/A
  • EPS
  • BOLT N/A
  • SAG 0.21
  • Revenue
  • BOLT $9,779,000.00
  • SAG $56,387,000.00
  • Revenue This Year
  • BOLT $9.87
  • SAG N/A
  • Revenue Next Year
  • BOLT N/A
  • SAG N/A
  • P/E Ratio
  • BOLT N/A
  • SAG $3.73
  • Revenue Growth
  • BOLT 35.86
  • SAG N/A
  • 52 Week Low
  • BOLT $0.42
  • SAG $0.47
  • 52 Week High
  • BOLT $1.56
  • SAG $8.27
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 36.26
  • SAG N/A
  • Support Level
  • BOLT $0.42
  • SAG N/A
  • Resistance Level
  • BOLT $0.48
  • SAG N/A
  • Average True Range (ATR)
  • BOLT 0.03
  • SAG 0.00
  • MACD
  • BOLT -0.00
  • SAG 0.00
  • Stochastic Oscillator
  • BOLT 16.00
  • SAG 0.00

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About SAG SAG HOLDINGS LTD

SAG Holdings Ltd engages in the business of distributing automotive and industrial spare parts with operations primarily based in Singapore, and global sales primarily generated from the Middle East and Malaysia. Its business is comprised of On-Highway Business serving the automotive sector and Off-Highway Business primarily servicing the marine, energy, mining, construction, agriculture, and oil and gas sectors. The On-Highway Business Segment supply genuine and aftermarket spare parts to customers through our Autozone retail outlets located in Singapore, as well as Malaysia. The Off-Highway Business Segment supply a wide range of components and spare parts for internal combustion engines with a strong focus on filtration products through Filtec.

Share on Social Networks: